SCHEMBL5151064

SCHEMBL5151064

Cc1ccc(NC(=O)[AsH]c2ccc(-c3ccc(C(=O)CC(C)(C)C(=O)O)cc3)cc2)cc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
MEN1 O00255 2/20 0.46
POLB P06746 3/20 0.42
DGAT1 O75907 3/20 0.39
FKBP5 Q13451 1/20 0.38
ALDH1A1 P00352 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
KDM1A O60341 1/20 0.37
MAOB P27338 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
NR1H4 Q96RI1 1/20 0.37
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4226915 0.88 RAB9A (0.50) KMT2ANPC1RAB9AMEN1POLB
SCHEMBL5071427 0.80 DGAT1 (0.44) KMT2ANPC1RAB9AMEN1POLB
SCHEMBL13752563 0.72 NPC1 (0.54) KMT2ANPC1RAB9AMEN1ALDH1A1
SCHEMBL5067991 0.71 RAB9A (0.50) KMT2ANPC1RAB9AMEN1POLB
SCHEMBL6032026 0.70 SMN1; SMN2 (0.39) KMT2ANPC1RAB9AMEN1DGAT1
SCHEMBL3100283 0.69 RAB9A (0.56) KMT2ANPC1RAB9AMEN1POLB
SCHEMBL12265910 0.69 ALDH1A1 (0.49) KMT2AMEN1ALDH1A1SMN1; SMN2MAPT
SCHEMBL13752572 0.68 RAB9A (0.58) KMT2ANPC1RAB9AMEN1POLB
SCHEMBL13752570 0.67 PSEN1 (0.58) KMT2ANPC1RAB9AMEN1ALDH1A1
SCHEMBL1748034 0.67 SMN1; SMN2 (0.44) RAB9AALDH1A1SMN1; SMN2MAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1874317-A2 PREPARATION AND USE OF ARYL ALKYL ACID DERIVATIVES FOR THE TREATMENT OF OBESITY Bayer Pharmaceuticals Corporation (US) 2008-01-09 EP disclosed
WO-2006113919-A2 ARYL ALKYL ACID DERIVATIVES FOR AND USE THEREOF BAYER PHARMACEUTICALS CORPORATION (US) 2006-10-26 WO disclosed